4,6,20,44 Combination of DPP-4 Inhibitors and GLP-1 Agonists: Because both DPP-4 inhibitors and GLP-1 agonists increase incretin, there has been interest in learning whether this combination could result in a synergistic A1C-lowering effect
This may include people with active cancer concerns, immune disorders, uncontrolled chronic illness, pregnancy or plans for pregnancy, complex medication regimens, bleeding disorders, severe allergies, kidney or liver concerns, unexplained symptoms, or a history of poor reactions to injectable products
What Are The Symptoms Of A Vitamin B12 Deficiency
Submitting more than one may result in a longer response time